iShares Biotechnology ETF | 497: Periodic update to fund prospectus
iShares Biotechnology ETF | SC 13G/A: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities by passive investors and certain institutions (Amendment)
iShares Biotechnology ETF | 497: Periodic update to fund prospectus
iShares Biotechnology ETF | SC 13G/A: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities by passive investors and certain institutions (Amendment)
iShares Biotechnology ETF | SC 13G: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities by passive investors and certain institutions
iShares Biotechnology ETF | SC 13G: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities by passive investors and certain institutions
iShares Biotechnology ETF | SC 13G/A: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities by passive investors and certain institutions (Amendment)
iShares Biotechnology ETF | 497: Periodic update to fund prospectus
iShares Biotechnology ETF | 497: Periodic update to fund prospectus
iShares Biotechnology ETF | 497: Periodic update to fund prospectus
iShares Biotechnology ETF | 497: Periodic update to fund prospectus
iShares Biotechnology ETF | 497: Periodic update to fund prospectus
iShares Biotechnology ETF | 497: Periodic update to fund prospectus
iShares Biotechnology ETF | 497: Periodic update to fund prospectus
iShares Biotechnology ETF | 497: Periodic update to fund prospectus
iShares Biotechnology ETF | SC 13G/A: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities by passive investors and certain institutions (Amendment)
iShares Biotechnology ETF | SC 13G/A: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities by passive investors and certain institutions (Amendment)
iShares Biotechnology ETF | SC 13G/A: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities by passive investors and certain institutions (Amendment)
iShares Biotechnology ETF | SC 13G/A: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities by passive investors and certain institutions (Amendment)
iShares Biotechnology ETF | SC 13G/A: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities by passive investors and certain institutions (Amendment)